In reference to the patent: [EP2600859A1](https://www.google.com/patents/EP2600859A1)

Has this patent been granted?

Does it mean that 1. all combination therapy consisting of beta-3 agonists in combination with muscarinic agonists have been patented by AltheRx OR just 
2. Solabegron in combination with muscarinic agonists have been patented by AltheRx?